A 52 year–old postmenopausal patient has evidence of low bone mineral density. She and her physician are considering therapy with raloxifene or a combination of conjugated estrogens and medroxyprogesterone acetate. Which of the following patient characteristics is MOST likely to lead them to select raloxifene?
Previous hysterectomy
Recurrent vaginitis
Strong family history of breast cancer
Troublesome hot flushes